Picture of Bristol-Myers Squibb Co logo

BMY — Bristol-Myers Squibb Co Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Momentum

Relative Strength (%)
1m+13.66%
3m+24.1%
6m+57.69%
1yr+23.56%
Volume Change (%)
10d/3m+0.42%
Price vs... (%)
52w High-3.19%
50d MA+1.79%
200d MA+15.94%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)9.74
PEG Ratio (f)0.3
EPS Growth (f)48.34%
Dividend Yield (f)2.86%
Valuation (ttm)IndustryMarket
Price to Book Value5.12
Price to Tang. Bookn/a
Price to Free Cashflow10.68
Price to Sales3.44
EV to EBITDA9.83

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11.1%
Return on Equity18.07%
Operating Margin18.97%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m20,77622,56126,14542,51846,38546,461.0648,363.2819.01%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+27.11+24.51-31.77n/an/a+99.07+7.38n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for BMY

Bristol-myers Squibb Co passes this 3-point dividend checklist background image

Bristol-myers Squibb Co passes this 3-point dividend checklist

For income investors watching volatile market conditions, the comfort of a regular, reliable dividend is hard to overstate. But finding these kinds of shares isn't easy... Excessive yields, weak financials and variable payouts can all...

Stock market volatility: Here's a large-cap worth a closer look background image

Stock market volatility: Here's a large-cap worth a closer look

Shares in Bristol-myers Squibb Co (NYQ:BMY) are currently trading at 60.01 but the question for investors is how much the market chaos of 2020 will impact on its price. The answer comes down to judging whether Bristol-myers Squibb Co i...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Bristol-Myers Squibb Co EPS forecast chart

Profile Summary

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. The Company’s pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company’s products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.

Directors

Last Annual
December 31st, 2021
Last Interim
March 31st, 2022
Incorporated
August 11th, 1933
Public Since
July 5th, 1929
No. of Shareholders
34,417
No. of Employees
32,200
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
2,129,064,271

BMY Share Price Performance

Latest News for BMY

Upcoming Events for BMY

Q2 2022 Bristol-Myers Squibb Co Earnings Call

Q2 2022 Bristol-Myers Squibb Co Earnings Release

Q3 2022 Bristol-Myers Squibb Co Earnings Call

Q3 2022 Bristol-Myers Squibb Co Earnings Release

Similar to BMY

Picture of Abbvie logo

Abbvie

us flag iconNew York Stock Exchange

Picture of Amneal Pharmaceuticals logo

Amneal Pharmaceuticals

us flag iconNew York Stock Exchange

Picture of Bausch Health Companies logo

Bausch Health Companies

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

Picture of Catalent logo

Catalent

us flag iconNew York Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email